Core Points - A class action lawsuit has been filed against RCI Hospitality Holdings, Inc. (NASDAQ: RICK) for allegedly making materially false and misleading statements regarding tax fraud and bribery [7] - The lawsuit claims that the defendants understated the legal risks facing the company, leading to investor damages when the true details were revealed [3] Allegation Details - Defendants allegedly engaged in tax fraud and bribery to conceal this fraud [3] - The lawsuit asserts that the defendants' statements about the company's business, operations, and prospects were materially false and lacked a reasonable basis [3] Next Steps - Investors who purchased RCI shares between December 15, 2021, and September 16, 2025, and suffered losses are encouraged to contact the law firm for more information [4][7] - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is November 20, 2025 [7]

Core Viewpoint - A class action lawsuit has been filed against Quanex Building Products Corporation for allegedly making materially false and misleading statements regarding its business operations and prospects during the specified class period [3][7]. Allegation Details - The lawsuit claims that Quanex failed to disclose significant underinvestment in tooling and equipment maintenance at its Tyman Mexico facility, leading to degraded conditions [3]. - It is alleged that the company was likely to incur substantial costs due to these issues, which would delay the expected benefits from the Tyman integration [3]. - The complaint asserts that Quanex had previously identified these problems but did not disclose them, rendering its positive statements about the company's operations misleading [3]. Next Steps - Investors who purchased Quanex shares between December 12, 2024, and September 5, 2025, and suffered losses are encouraged to contact the law firm for more information and to discuss their rights [4][7]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is November 18, 2025 [7]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation across the United States [5].

Core Viewpoint - A class action lawsuit has been filed against Savara Inc. for failing to disclose critical information regarding the MOLBREEVI Biologics License Application, leading to significant investor losses [8]. Allegation Details - The lawsuit claims that during the class period from March 7, 2024, to May 23, 2025, Savara did not disclose that the MOLBREEVI BLA lacked sufficient information on chemistry, manufacturing, and controls, making FDA approval unlikely [8]. - The complaint also states that the delay in regulatory approval would likely necessitate Savara to raise additional capital [8]. - Following the announcement of a refusal to file letter from the FDA on May 27, 2025, Savara's stock price dropped by $0.90, or 31.69%, closing at $1.94 per share [8]. Next Steps - Investors who purchased Savara shares and suffered losses are encouraged to contact the law firm for more information and to discuss their legal rights [4]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is November 7, 2025 [8]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation across the United States [5].

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Dow To Contact Him Directly To Discuss Their Options If you purchased or acquired Dow securities between January 30, 2025 and July 23, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squir ...

Core Points - A class action lawsuit has been filed against Semler Scientific, Inc. for allegedly making materially false and misleading statements regarding a Department of Justice investigation into violations of the False Claims Act [3][7] - The lawsuit claims that investors who purchased Semler securities between March 10, 2021, and April 15, 2025, suffered damages when the true details of the investigation were revealed [3][7] - Investors have until October 28th to apply to the Court to be appointed as lead plaintiff in the lawsuit [7] Allegation Details - The complaint alleges that Semler Scientific failed to disclose a material investigation by the DOJ while discussing potential violations of the False Claims Act in hypothetical terms [3] - Defendants' public statements were claimed to be materially false and misleading at all relevant times due to the lack of disclosure regarding the investigation [3] Next Steps - Investors who suffered losses and are interested in learning more about the claims or have questions are encouraged to contact the law firm Bragar Eagel & Squire, P.C. [4] - There is no cost or obligation for investors to reach out for more information [4] About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation across state and federal courts [5] - The firm has offices in New York, California, and South Carolina [5]

Core Viewpoint - RCI Hospitality Holdings, Inc. is facing a class action lawsuit due to allegations of tax fraud and bribery, which resulted in misleading statements about the company's business and legal risks [2][4]. Group 1: Allegations and Class Period - The class period for the lawsuit is from December 15, 2021, to September 16, 2025 [2]. - Allegations include that defendants engaged in tax fraud and bribery to cover up the fraud, leading to an understatement of legal risks and materially false statements regarding the company's operations and prospects [2]. Group 2: Shareholder Actions - Shareholders who purchased shares during the class period are encouraged to register for the class action and can seek lead plaintiff status by the deadline of November 20, 2025 [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [3]. Group 3: Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices, seeking recovery for losses incurred due to misleading statements or omissions [4].

Core Viewpoint - RCI Hospitality Holdings, Inc. is facing a class action lawsuit due to allegations of tax fraud and bribery, which resulted in misleading statements about the company's business and legal risks [3][4]. Summary by Relevant Sections Allegations - The complaint alleges that during the class period from December 15, 2021, to September 16, 2025, the defendants engaged in tax fraud and bribery to conceal this fraud [3]. - It is claimed that these actions led to an understatement of the legal risks facing the company, resulting in materially false and misleading statements regarding its business operations and prospects [3]. Class Action Details - Shareholders who purchased shares of RCI Hospitality Holdings during the specified class period are encouraged to register for the class action, with a deadline set for November 20, 2025 [4]. - Participants will be enrolled in a portfolio monitoring system to receive updates on the case's progress [4]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [5].

Core Viewpoint - A class action lawsuit has been filed against Fortinet, Inc. for alleged misrepresentations regarding its product refresh cycle and the true number of FortiGate firewalls eligible for upgrades, leading to significant investor losses [7]. Allegation Details - The lawsuit claims that Fortinet's management misrepresented the potential profitability of the refresh cycle, stating it would not be as lucrative as suggested due to the age and limited scope of the products involved [7]. - It is alleged that Fortinet concealed the uncertainty regarding the number of FortiGates that required upgrades and misled investors about the momentum of the refresh cycle [7]. - Following the earnings call on August 6, 2025, where Fortinet disclosed that it was only 40% to 50% through the upgrade cycle, the stock price dropped over 22% [7]. Next Steps - Investors who purchased Fortinet shares during the specified class period (November 8, 2024, to August 6, 2025) and suffered losses are encouraged to contact the law firm for more information and to discuss their legal rights [4]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is November 21, 2025 [7]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation across various courts in the United States [5].

Core Viewpoint - BNP Paribas is facing significant stock declines due to a court ruling linking the bank to human rights abuses in Sudan, raising concerns about potential settlement payouts that could reach billions [1][3]. Group 1: Stock Performance - The stock dropped approximately 8% following a court loss in the US, where three Sudanese plaintiffs were awarded damages for BNP's alleged support of the Sudanese regime [3]. - The total verdict was $21 million, but there are over 20,000 additional plaintiffs in the US, indicating a potential for much larger financial liabilities [3][4]. Group 2: Legal Implications - The ongoing legal case presents a new risk for BNP Paribas that may not have been fully recognized previously, suggesting that the bank could face substantial costs [4]. - Lawyers for the plaintiffs have indicated that BNP Paribas should consider settling, with figures being discussed in the low billions [5]. Group 3: Market Reaction - The market appears to be reacting to worst-case scenarios due to the uncertainty surrounding the potential financial impact of the legal issues [5]. - Despite the stock's significant drop, some analysts suggest that the declines may be overdone until more clarity is provided regarding the actual risks involved [5].

Core Viewpoint - A class action lawsuit has been filed against aTyr Pharma, Inc. regarding allegations of securities fraud and unlawful business practices following disappointing clinical trial results [2][4]. Group 1: Lawsuit Details - The class action lawsuit concerns whether aTyr and certain officers and/or directors engaged in securities fraud or other unlawful business practices [2]. - Investors have until December 8, 2025, to request appointment as Lead Plaintiff if they purchased aTyr securities during the Class Period [2]. Group 2: Clinical Trial Results - On September 15, 2025, aTyr announced that the EFZO-FIT study, a Phase 3 trial for intravenous Efzofitimod in pulmonary sarcoidosis patients, did not meet its primary endpoint [4]. - Following the announcement of the trial results, aTyr's stock price fell by $5.01 per share, or 83.17%, closing at $1.01 per share [5]. Group 3: Company Background - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of recovering multimillion-dollar damages for class members [6].